Tolaney, S. M., Jiang, Z., Zhang, Q., Barroso-Sousa, R., Park, Y. H., Rimawi, M. F., Saura, C., Schneeweiss, A., Toi, M., Chae, Y. S., Kemal, Y., Chaudhari, M., Şendur, M. A., Yamashita, T., Casalnuovo, M., Danso, M. A., Liu, J., Shetty, J., Herbolsheimer, P., Loibl, S. (2026). Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2508668